The numbers IEX said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.
Of 2 range targets with a reported result: 1 came in above the last range given, 0 within it, 1 below it.
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Diluted EPS (company-defined) Fiscal 2026 |
Given $8.35 to $8.55 release 2026-04-29
Raised $8.70 to $8.85 release 2026-07-29
|
– | No standard number |
The company's wordsRaising full year 2026 organic growth and adjusted EPS guidance ranges … Full year adjusted diluted EPS of $8.35 to $8.55, up from previous guidance of $8.15 to $8.35 release 2026-04-29 Raising full year 2026 organic growth and adjusted EPS guidance ranges … Full year adjusted diluted EPS of $8.70 to $8.85, up approximately 10% year- over-year at midpoint, up from previous guidance of $8.35 to $8.55 release 2026-07-29 | |||
| Diluted EPS (company-defined) Q3 of fiscal 2026 |
Given $2.20 to $2.25 release 2026-07-29
|
– | No standard number |
The company's wordsRaising full year 2026 organic growth and adjusted EPS guidance ranges … Third quarter 2026 adjusted diluted EPS of $2.20 to $2.25 release 2026-07-29 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2026 |
Given $2.07 to $2.12 release 2026-04-29
|
– | No standard number |
The company's wordsRaising full year 2026 organic growth and adjusted EPS guidance ranges … Second quarter 2026 adjusted diluted EPS of $2.07 to $2.12 release 2026-04-29 | |||
| Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $6.56 to $6.95 release 2025-05-01
Lowered $6.30 to $6.44 release 2025-07-30
Narrowed $6.35 to $6.40 release 2025-10-29
|
– | No standard number |
The company's wordsIn 2025, the Company expects to generate GAAP diluted EPS of $6.56 - $6.95 (adjusted diluted EPS of $8.10 - $8.45), based on expected full year organic sales growth of 1% to 3%. release 2025-05-01 In 2025, the Company now expects to generate GAAP diluted EPS of $6.30 - $6.44 (adjusted diluted EPS of $7.85 - $7.95) a change from previous guidance of $6.56 - $6.95 (adjusted diluted EPS of $8.10 - $8.45), based on expected full year organic sales growth of approximately 1%. release 2025-07-30 Full Year 2025 GAAP diluted EPS narrowed to $6.35 - $6.40 (adjusted diluted EPS narrowed to $7.86 - $7.91), within prior guidance range release 2025-10-29 | |||
| Diluted EPS Fiscal 2025 (ended 2025-12-31) |
Given $6.35 to $6.40 release 2025-10-29
|
$6.41 10-K filed 2026-02-19 |
Above the range |
The company's wordsGuidance(4) Full Year 2025 … Estimated diluted EPS attributable to IDEX $6.35 - $6.40 release 2025-10-29 | |||
| Diluted EPS (company-defined) Q3 of fiscal 2025 |
Given $1.54 to $1.61 release 2025-07-30
|
– | No standard number |
The company's wordsIn the third quarter 2025, the Company expects to generate GAAP diluted EPS of $1.54 - $1.61 (adjusted diluted EPS of $1.90 - $1.95), based on expected third quarter 2025 organic sales growth of 2% to 3%. release 2025-07-30 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2025 |
Given $1.60 to $1.72 release 2025-05-01
|
– | No standard number |
The company's wordsIn the second quarter 2025, the Company expects to generate GAAP diluted EPS of $1.60 - $1.72 (adjusted diluted EPS of $1.95 - $2.05), based on expected second quarter 2025 organic sales growth of 0% to 2%. release 2025-05-01 | |||
| Diluted EPS (company-defined) Q1 of fiscal 2025 |
Given $1.60 to $1.65 release 2025-02-04
|
– | No standard number |
The company's wordsGuidance First Quarter 2025 Full Year 2025 Estimated diluted EPS … Estimated adjusted diluted EPS attributable to IDEX $1.60 - $1.65 release 2025-02-04 | |||
| Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $7.15 to $7.45 release 2024-02-07
Lowered $7.13 to $7.43 release 2024-04-24
Lowered $6.85 to $6.95 release 2024-08-01
Raised $7.85 to $7.90 release 2024-10-30
|
– | No standard number |
The company's wordsFull year 2024 organic sales growth is projected to be 0% to 2% over the prior year, with GAAP diluted EPS of $7.15 to $7.45 (adjusted diluted EPS of $8.15 to $8.45). release 2024-02-07 Full Year and Second Quarter 2024 Outlook … Full year GAAP diluted EPS of $7.13 - $7.43 (adjusted diluted EPS of $8.15 - $8.45) release 2024-04-24 Revised Full Year and Third Quarter 2024 Outlook … Full year GAAP diluted EPS of $6.85 - $6.95 (adjusted diluted EPS of $7.80 - $7.90), down from previous guidance of $7.13 - $7.43 (adjusted diluted EPS of $8.15 - $8.45) release 2024-08-01 Full Year 2024 Outlook … Adjusted diluted EPS of $7.85 - $7.90 vs. previous guidance of $7.80 - $7.90 release 2024-10-30 | |||
| Diluted EPS Fiscal 2024 (ended 2024-12-31) |
Given $6.65 to $6.70 release 2024-10-30
|
$6.64 10-K filed 2025-02-20 |
Below the range |
The company's wordsFull Year 2024 Outlook … Full year GAAP diluted EPS of $6.65 - $6.70 vs. previous guidance of $6.85 - $6.95. release 2024-10-30 | |||
| Diluted EPS (company-defined) Q4 of fiscal 2024 |
Given $2.01 to $2.06 release 2024-10-30
|
– | No standard number |
The company's wordsGuidance Fourth Quarter 2024 Full Year 2024 Estimated diluted EPS attributable … Estimated adjusted diluted EPS attributable to IDEX $2.01 - $2.06 release 2024-10-30 | |||
| Diluted EPS (company-defined) Q3 of fiscal 2024 |
Given $8.15 to $8.45 release 2024-08-01
|
– | No standard number |
The company's wordsRevised Full Year and Third Quarter 2024 Outlook … Full year GAAP diluted EPS of $6.85 - $6.95 (adjusted diluted EPS of $7.80 - $7.90), down from previous guidance of $7.13 - $7.43 (adjusted diluted EPS of $8.15 - $8.45) release 2024-08-01 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2024 |
Given $1.75 to $1.80 release 2024-04-24
|
– | No standard number |
The company's wordsFull Year and Second Quarter 2024 Outlook … Second quarter GAAP diluted EPS of $1.75 - $1.80 (adjusted diluted EPS of $2.00 - $2.05) release 2024-04-24 | |||
| Diluted EPS (company-defined) Q1 of fiscal 2024 |
Given $1.45 to $1.50 release 2024-02-07
|
– | No standard number |
The company's wordsFirst quarter 2024 organic sales are projected to decline 6% to 7% from the prior year period, with GAAP diluted EPS of $1.45 to $1.50 (adjusted diluted EPS of $1.70 to $1.75). release 2024-02-07 | |||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-07), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Work on IEX in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/IEX/export.csv") into a cell.